08:15 Welcome coffee

08:45 Opening Ceremony. Khalil Fattouch, Patrizio Lancellotti

09:00 What is new in valvular heart disease in 2026
Chairs: Gilbert Habib, Patrizio Lancellotti, Vincenzo Polizzi

09:00 ESC Guidelines vs AHA/ACC Guidelines: what are the key differences? Augustin Coisne
09:10 Multimodality imaging in valvular disease: what has changed in the last years? Mani Vannan
09:20 Cardiac damage staging in valvular heart disease: a new paradigm for risk stratification. Tommaso Viva
09:30 Artificial intelligence in valvular imaging: hype or clinical reality? Bernard Cosyns
09:40 Valve durability in the era of lifetime management. Philippe Pibarot
09:50 Discussion: Eustachio Agricola, Raluca Dulgheru, Vlatka Reskovic Luksic

10:00 Flash updates: new concepts in valvular heart disease
Chairs: Carlo Caserta, Sergio Fasullo, Salvatore Martino

10:00 When “moderate” is not benign: rethinking risk in multivalvular VHD. Giorgia Benzoni
10:10 Arrhythmic mitral valve: what are we getting mad about? Thierry Le Tourneau
10:20 Discussion: Tommaso Viva, Federica Ilardi, Fabio Triolo

10:30 Coffee break and poster display of accepted abstracts

11:00 ricuspid regurgitation: from disease staging to treatment
Chairs : Alain Berrebi, Rodolfo Citro, Michele Gabriele

11:00 Natural history of TR under optimal medical therapy. Caterina Gandolfo
11:10 RV dysfunction: marker of severity or point of no return? Mani Vannan
11:20 Clinical and imaging markers to guide intervention in tricuspid regurgitation. Vicenzo Polizzi
11:30 Transcatheter tricuspid therapies: lessons from recent RCT. Erwan Donal
11:40 When and how to treat patients with TR. Julien Dreyfus
11:50 Discussion: Salvatore Torres, Krzysztof Smarż, Alessio Martinelli

12:00 Flash news: polymeric valve technologies in development
Chairs : Antonio D’Amore, Ignazio Niosi, Pietro Terranova

Panelists: John Carney, Ryan Stanfield

12:30 Lunch break and poster display of accepted abstracts

13:30 Mitral regurgitation: complex pathophysiology and management
Chairs: Carlo Cicerone, Massimo Benedetto, Salvatore Geraci

13:30 TEER for whom? Eustachio Agricola
13:40 Persistent MR after TEER: should we reclip? Konstantinos Papadopoulos
13:50 MR and complex anatomy: TMVR? Alessandro Sticchi
14:00 Roman arch: a new way to repair mitral valve. Konstantinos Zannis
14:10 Discussion: Mathieu Lempereur, Jadranka Separovic

14:30 Valve prostheses: durability, dysfunction and long-term management
Chairs: Antonio Micari, Cécile Oury, Alfredo Galassi

14:30 Structural valve deterioration: from mechanisms to clinical impact. Julien Ternacle
14:40 Multimodality imaging of prosthetic valve endocarditis. Gilbert Habib
14:50 Bioprosthetic valve thrombosis and leaflet thickening: clinical relevance. Marco Moscarelli
15:00 Lifetime management for aortic stenosis. Corrado Tamburino
15:10 Discussion: Cameron Haskoy, Enrico Boni, Giovanni La Fiura

15:20 Complex scenarios
Chairs: Corrado Tamburino, Khalil Fattouch

15:20 Redo strategies for failed bioprostheses: surgery or valve-in-valve? Geu-Ru Hong
15:30 Ross procedures for aortic valve stenosis. Domenico Paparella
15:40 Redo Tavi. Marco Barbanti
15:50 Discussion: Carline Celentano, Ciro Santoro, Gregorio Zaccone

16:00 Dr Jekyll and Mr Hyde session I
Chairs: Alfredo Galassi, Patrizio Lancellotti

Patients with moderate AS and reduced LVEF should undergo early TAVR:

16:00 Pro. Philippe Pibarot
16:10 Con. Philippe Pibarot
16:20 Discussion: Samuel Bruls, Luca Bullitta, Carmine Celentano

16:30 Coffee break and poster display of accepted abstracts

17:00 Aortic regurgitation: current strategies and unresolved questions
Chairs: Gilbert Habib, Salvatore Lentini, Linda Pisano

17:00 Key insights into aortic valve anatomy. Alain Berrebi
17:10 Key insights into imaging and quantification. Konstantinos Papadopoulos
17:20 Key insights into surgical strategies. Alessandro Della Corte
17:30 Key insights into transcatheter therapies. Rodolfo Citro, Michele Bellino
17:40 Discussion: Myriam Lo Presti, Vlatka Reskovic Luksic, Cameron Haskoy

17:50 Flash news: Jenavalve current technologies for aortic regurgitation. Bastian Schön

18:00 The best accepted abstracts

Chairs: Bernard Cosyns, Carla De Sousa, Antonio Rubino

18:00 Cardiac Adipose Tissue and Perioperative Biological Vulnerability After TAVI. Roberta Madonia
18:05 Three-Dimensional Evaluation of Valvular and Perivalvular Thrombosis After Self-Expanding Transcatheter Aortic Valve Implantation. Maria Chiara Greco
18:10 Reasons for TAVI turn-down and early outcomes of subsequent surgical aortic valve replacement: a single-centre cohort study. Simonette Carlton-Carew
18:15 Beyond Pannus and Thrombosis: Progressive Rheumatic Subvalvular Fibro-Calcific Remodeling as an Underrecognized Mechanism of Prosthetic Mitral Dysfunction. Valentina Parisi